One of our previous studies showed that detection of autoantibodies in cancer can be enhanced by using a mini-array of seven TAAs as target antigens which included c-Myc, p53, cyclin B1, IMP2/p62, Koc, IMP1, and survivin [21, 46]. Here, BIRC5 is linked to cancer.